pipeline

ANG-3070

ANG-3070, is a highly selective, oral small molecule tyrosine kinase receptor inhibitor developed internally as a potential treatment for chronic fibrotic diseases, particularly in the kidney and lung. ANG-3070 is an investigational product and is not approved by any regulatory authority.

ROCK2 Inhibitor

CYP11B2 Inhibitor